|
|
|||
|
||||
OverviewFull Product DetailsAuthor: Ajit S. Narang (Bristol Myers Squibb, NJ, USA) , Sherif I.F. Badawy (Bristol-Myers Squibb Company, NJ, USA)Publisher: Elsevier Science Publishing Co Inc Imprint: Academic Press Inc Edition: 2nd edition Weight: 0.450kg ISBN: 9780443298172ISBN 10: 0443298173 Pages: 964 Publication Date: 01 December 2025 Audience: Professional and scholarly , Professional & Vocational Format: Hardback Publisher's Status: Active Availability: In Print This item will be ordered in for you from one of our suppliers. Upon receipt, we will promptly dispatch it out to you. For in store availability, please contact us. Table of Contents1. Process Analytical Technologies to Study Granule Densification and Cohesion 2. Power consumption-based granulation end point: Does it Predict Scale-up? 3. A quality by design approach using artificial intelligence techniques to control the critical quality attributes of ramipril tablets manufactured by wet granulation 4. Commonly used Mathematical Models in Wet Granulation 5. Elucidating Molecular Mechanisms of Wet Granulation using NIR Detection of Water and the Effect on Tablet Dissolution 6. Multivariate Analysis for Process Control of High Shear Wet Granulation 7. Impact of Granulation Techniques on Granule and Tablet Properties 8. Material Physical Modifications Induced by Wet Granulation (Current chapter 6) 9. Spectroscopic Methods for Real-time Monitoring of Pharmaceutical Wet Granulation 10. Continuous Twin Screw Granulation: A Review of Recent Progress and Opportunities in Formulation and Equipment Design 11. Artificial Intelligence Tools for Scaling Up of High Shear Wet Granulation Process 12. Model driven design for twin screw granulation using mechanistic-based population balance model 13. Machine learning models for prediction of granule properties in twin screw granulation 14. Design and scale up of fluid bed granulation 15. Process analytical methods for monitoring of pharmaceutical wet granulationReviewsAuthor InformationAjit S. Narang works for the Bristol-Myers Squibb, Co. in New Brunswick, New Jersey, in the biopharmaceutical aspects of drug delivery. He has more than eight years of experience in the pharmaceutical industry in the development of oral dosage forms and drug delivery platforms. In addition to the Bristol-Myers Squibb, Co., he has worked for Ranbaxy Research Labs (currently a subsidiary of Daiichi Sankyo, Japan) in Gurgaon, India, and Morton Grove Pharmaceuticals (currently a subsidiary of Wockhardt USA LLC, Parsippany, New Jersey) in Vernon Hills, Illinois. He has more than 35 publications and three pending patent applications and has contributed to the development of several marketed drug products. Sherif Badawy, Ph.D., is a Research Fellow in the Drug product Science and Technology of the Bristol-Myers Squibb Company. He received his B.S. in Pharmacy and M.S. in Pharmaceutics from Cairo University, and his Ph.D. in Pharmaceutics from Duquesne University. He has more than 20 years of industrial experience in drug product development. His current responsibilities at Bristol-Myers Squibb include formulation and process development and scale-up of commercial oral solid and liquid dosage forms. His areas of research interest include high shear wet granulation, tablet compaction, stability of solid dosage forms and bioavailability enhancement of poorly water-soluble compounds. He authored more than 40 manuscripts and numerous abstracts and presentations in those areas. Tab Content 6Author Website:Countries AvailableAll regions |
||||